Delivery Order SPE2DB20D2001-SPE2DB25FPLTP
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,666.97, is for the delivery of XIFAXAN 550 mg tablets. The contract has a firm fixed price and an ultimate completion date of September 11, 2024. It is a delivery order contract, which indicates it is part of a larger contracting vehicle. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,506.28 firm fixed-price contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of October 13, 2022.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,497.29 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of May 5, 2023.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $30,902.72, awarded by the Defense Logistics Agency (DLA) for the supply of XIFAXAN 550 MG TABLET 60S. The contract has an ultimate completion date of July 17, 2024. Amerisourcebergen, the prime contractor, is a major pharmaceutical distributor that provides a wide range of medical products and supplies to the U.S. federal government, including military treatment facilities and veterans' healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,720.65 firm-fixed-price delivery order is for the supply of XIFAXAN 550 mg tablets, a specialty medication. The contract has an ultimate completion date of October 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $9,094.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC), is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has a period of performance through November 4, 2024, and utilizes a Firm Fixed Price (FFP) pricing type. The award was...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $79,062.53, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a June 13, 2022 completion date. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,736.48 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a period of performance through December 27, 2024.
The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,906.15 Firm Fixed Price Delivery Order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. The contract is not designated as a set-aside.
AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of XIFAXAN 550 mg tablets. The $4,651.78 firm-fixed-price delivery order has a completion date of May 8, 2023. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and is not subject to any set-aside requirements. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...